|
Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998. |
|||||||||||||||||||||
Tarsus Pharmaceuticals, Inc. - Common Stock (NQ:TARS)Price and VolumeDetailed Quote
Top NewsMore News
Tarsus to Participate in Upcoming Investor Conference
November 05, 2025
PerformanceMore NewsRead More
Earnings Scheduled For November 4, 2025
November 04, 2025
Earnings Scheduled For August 6, 2025
August 06, 2025
Earnings Scheduled For May 1, 2025
May 01, 2025
An Overview of Tarsus Pharmaceuticals's Earnings
April 30, 2025
Tarsus to Participate in Upcoming Investor Conferences
August 27, 2025
3 Biotech Catalysts Present Major Opportunity
August 25, 2025
Top 2 Health Care Stocks That May Fall Off A Cliff In August
August 20, 2025
Frequently Asked QuestionsIs Tarsus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Tarsus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Tarsus Pharmaceuticals, Inc. - Common Stock trade on?
Tarsus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tarsus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Tarsus Pharmaceuticals, Inc. - Common Stock is TARS on the Nasdaq Stock Market
What is the current price of Tarsus Pharmaceuticals, Inc. - Common Stock?
The current price of Tarsus Pharmaceuticals, Inc. - Common Stock is 68.09
When was Tarsus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Tarsus Pharmaceuticals, Inc. - Common Stock was at 11/06/25 04:00 PM ET
What is the market capitalization of Tarsus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Tarsus Pharmaceuticals, Inc. - Common Stock is 2.33B
How many shares of Tarsus Pharmaceuticals, Inc. - Common Stock are outstanding?
Tarsus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
||||||||||||||||||||
|
|||||||||||||||||||||